Sch-42495

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSch-42495
Drug Alias NameSch-42495
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeprilysin inhibitors
TargetsNeprilysin
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme Corp
Active IndicationsN/A
Inactive IndicationsHypertensionHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A